flecha

Product

flecha
Technological Platform
Technological Platform Technological platform to reconsider molecules with angiogenic activities using robotic system.
High Throughput Screening (HTS) technologies have been widely accepted by pharmaceutical and biotechnology companies as an integral part of their drug discovery processes. Cell based high-content screening (HCS) – an extended version of HTS – is also being used more frequently to screen a larger number of compound libraries. Cell-based assays can be used to test compounds directly on living cells, which helps generate quality leads as well as hastens the process of lead validation.

Full integration of increasingly sophisticated cell analysis tools with enabling hardware will allow advancement of target validation and screening from ‘high-content’ to ‘high-context’ screening (HCxtS).
 
Link More information
 
Tags   cro
Permalink  
Delicious  Technorati  Facebook  Twitter  Meneame 
Search
linea
Google Custom Search
BioRegión Collaborative Area
BioRegión Collaborative Area
RSS
linea
RSS RSS Andalucía BioRegión
User Acces
linea
Email:
Password:

Register

Forgot your password?

Companies/centers Acces
line
Email:
Password:

Register your company

Forgot your password?

Tag cloud
line
View more tags
BioRegión Collaborative Area